Photo of Jaime Chu
Accepting New Patients

Jaime Chu, MD Email Jaime Chu

Doctor magenta, checkmark badge icon
Mount Sinai Doctors ?
    • Position
    • ASSOCIATE PROFESSOR | Pediatrics, Hepatology
    • Specialties
    • Pediatrics
    • Liver Transplantation
    • Pediatric Hepatology
    • Language
    • English
    • Hospital Affiliation
    • The Mount Sinai Hospital
    • Phone
    • RMTI Pediatric Liver Disease and Transplantation 212-659-8060
    • Hepatitis C Clinic 212-659-8060
Request an Appointment

Dr. Jaime Chu is the Mount Sinai Endowed Professor of Pediatric Liver Research, the Associate Chief of the Division of Pediatric Hepatology, and  the Director of the Pediatric Physician-Scientist Residency Program at the Mount Sinai Kravis Children’s Hospital and Mount Sinai’s Recanati/Miller Transplantation Institute. She received her B.A. magna cum laude from Harvard University and her M.D. from New York University School of Medicine.  She completed her General Pediatrics residency training at Northwestern University/Children’s Memorial Hospital (now Lurie Children's Hospital of Chicago) at Northwestern University in Chicago, IL and her fellowship in Pediatric Gastroenterology, Hepatology, and Nutrition both at Children’s Memorial Hospital and at the Mount Sinai School of Medicine.

Dr. Chu is a physician-scientist in pediatric hepatology. She runs an NIH R01-funded basic research group that focuses on how sugar metabolism pathways work together to sustain rapid cell growth in liver development and disease. The lab focuses on the role of mannose metabolism pathways in liver fibrosis. The Chu Lab capitalizes on the strength of the zebrafish as a tool to investigate metabolic mechanisms of hepatic stellate cell activation and test potential therapies to dampen the fibrogenic response. Her research has been awarded the Gilead Sciences Research Scholars Liver Disease Award, AASLD Foundation Bridge Award and R01 funding from the NIH/NIDDK to examine the role of mannose metabolism in liver fibrosis. Dr. Chu's clinical research includes participation as site PI and co-Investigator in NIH-funded consortia including a U01 Pediatric Acute Liver Failure, and other Industry-sponsored pediatric drug trials for genetic cholestatic liver disease, biliary atresia, and viral hepatitis. Dr. Chu's long-term goal is to utilize collaborative science and integrate basic and clinical research towards improving our understanding of the mechanisms underlying pediatric liver disease and to apply this knowledge towards the development of much needed therapeutic options for children with liver disease. For more information, please see the Chu Lab website:

Dr. Chu is a member of the NIDDK Study Section for Fellowship Awards and is currently serving as a member of the AASLD Task Force on COVID-19.


Pediatric Gastroenterology

Clinical Focus

Research Topics

Apoptosis/Cell Death, Biochemistry, Biomedical Sciences, Cancer, Cell Biology, Developmental Biology, Environmental Health, Fibrosis, Gastroenterology, Gene Regulation, Glycobiology, Inflammatory Bowel Disease (IBD), Metabolism, Obesity, Oncogenes, Organ Donation, Organogenesis, Patient Care, Patient Centered Outcomes Research, Pediatrics, Protein Structure/Function, Protein Translation, Regeneration, Signal Transduction, Translational Research, Transplantation, Tumor Suppressor Genes


MD, New York University School of Medicine

BA, Harvard University

Residency, Pediatrics
Children's Memorial Hospital

Fellowship, Pediatric Gastroenterology
Children's Memorial Hospital

Fellowship, Pediatric Gastroenterology
Westmed Medical Group